ARCHIVES

Letter to the Editors: Loss Of ET2 Would Be Disheartening, Member Of Study Section Says

This article is from The Cancer Letter archive.

Vol. 24 No. 07 | February 20, 1998

Download PDF Visit The Full Archive

Related Articles

Eight Scientists Receive $800,000 From Milken

January 5, 1990

NCI Requests $5.69 Billion To Seize Opportunities In FY03.

January 11, 2002

DCPC Advisors Okay Minority Based CCOPs, RFA In Native Americans

January 15, 1993

NCI Advisory Group, Other Cancer Meetings For Sept,. Oct,. Future

August 25, 1989

FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says.

January 14, 2005

Marker Research Plans Described; NCAB May Consider Asking For Special Study Section For Those Grants

March 11, 1983